Founders Fund

Founders Fund, established in 2005 and headquartered in San Francisco, is a venture capital firm that invests across various stages and sectors globally. It focuses on companies developing transformative technologies, with a particular interest in science and engineering ventures. These include consumer internet, biotechnology, aerospace and transportation, energy, artificial intelligence, and health. The firm's investment size ranges from $500,000 to $300 million, providing maximum support with minimum interference to its portfolio companies. Founders Fund is known for its founder-friendly approach and has been an early backer of prominent companies like SpaceX, Palantir, Facebook, and Airbnb.

Jennifer Campbell

Partner

Lauren Gross

Partner and COO

Bridget Harris

Associate

Sean Liu

Partner

Jeffrey Lonsdale

Managing Director, Asia

John Luttig

Partner

Amin Mirzadegan

Partner

Luke Nosek

Managing Partner

Stephen Oskoui

Venture Partner

Neil Ruthven

CFO

Eric Scott

Principal

Matias Van Thienen

Partner

Past deals in Health Diagnostics

Ataraxis

Series A in 2025
Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Even

Series A in 2024
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

9amHealth

Series A in 2024
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Even

Convertible Note in 2022
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.

Ultima Genomics

Venture Round in 2022
Ultima Genomics is a biotechnology company established in 2016 and headquartered in Newark, California. It specializes in genome-scale sequencing technology, focusing on providing analytical services to various enterprises. By employing an open substrate, Ultima Genomics creates a vast, low-cost reaction surface that facilitates billions of reads without relying on expensive flow cells or complex fluidic systems. The company utilizes specialized sequencing hardware combined with machine learning techniques to ensure reproducible and accurate results. This innovative approach enables clients to obtain genomic reports at scale, enhancing the speed and efficiency of sequencing while significantly reducing costs. Ultima Genomics aims to harness the potential of genomic information to drive advancements in biology and improve human health.

Ostro

Series B in 2022
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

9amHealth

Series A in 2022
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Garner Health

Series B in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Teiko.bio

Venture Round in 2021
Teiko.bio is an immune profiling company founded in 2020 and based in Salt Lake City, Utah. The company has developed a platform that identifies immune features linked to patient response, assesses the abundance and activation scores of various immune cell types, and suggests rational targets for combination therapies. By enabling clinicians to make informed treatment decisions, Teiko.bio aims to enhance patient outcomes and facilitate new discoveries in therapeutic pathways.

9amHealth

Seed Round in 2021
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

HeartLab

Seed Round in 2021
HeartLab is a leading provider of cardiac imaging solutions, specializing in the development of AI-based diagnostic tools aimed at improving the diagnosis and treatment of cardiovascular diseases. The company's platform integrates the entire imaging workflow, enhancing collaboration among healthcare professionals and streamlining processes to improve efficiency and outcomes. By utilizing advanced deep learning technologies, HeartLab's tools enable clinicians to extract detailed information from echocardiograms while automating repetitive tasks, significantly reducing the time required for measurements and interpretations. This focus on enhancing the practitioner experience aims to accelerate advancements in cardiology and elevate care for patients worldwide.

Calibrate

Series B in 2021
Calibrate Health, Inc., established in 2020 and based in New York, specializes in digital metabolic health services for sustainable weight loss. The company combines FDA-approved metabolic medications with a comprehensive curriculum and personalized virtual coaching to address the root causes of weight issues and promote long-term behavior change. Calibrate's approach, led by experts in obesity and nutrition science, aims to improve metabolic health and drive lasting results.

Even

Seed Round in 2021
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.

Maximus

Seed Round in 2021
Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Clearing

Seed Round in 2021
Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Collective Health

Series F in 2021
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Garner Health

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

HeartLab

Seed Round in 2020
HeartLab is a leading provider of cardiac imaging solutions, specializing in the development of AI-based diagnostic tools aimed at improving the diagnosis and treatment of cardiovascular diseases. The company's platform integrates the entire imaging workflow, enhancing collaboration among healthcare professionals and streamlining processes to improve efficiency and outcomes. By utilizing advanced deep learning technologies, HeartLab's tools enable clinicians to extract detailed information from echocardiograms while automating repetitive tasks, significantly reducing the time required for measurements and interpretations. This focus on enhancing the practitioner experience aims to accelerate advancements in cardiology and elevate care for patients worldwide.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Siren

Series B in 2020
Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Ostro

Series A in 2019
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in at-home diagnostic solutions, focusing on urine testing kits. Founded in 2018 and headquartered in Los Angeles, California, Scanwell Health has developed an FDA-cleared urine testing application that allows users to obtain clinical-grade results via their smartphones. The company's flagship product is a urinary tract infection test kit that not only provides accurate testing results but also connects users with online medical professionals for same-day treatment and prescriptions. By combining innovative technology with accessible healthcare services, Scanwell Health aims to enhance proactive health management for individuals seeking convenient and affordable medical care.

Tempo

Series A in 2019
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Collective Health

Series E in 2019
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Untitled Labs

Seed Round in 2019
Untitled Labs, Inc. is a consumer application idea lab based in San Francisco, California, founded in 2018. The company focuses on testing and developing innovative business ideas in various sectors, including social and professional networking, mobility, personal finance, premium services, health and wellness, travel, photography, and dating. Led by serial entrepreneur Roger Dickey, Untitled Labs aims to create valuable technology products that resonate with large audiences. By systematically evaluating multiple concepts, the company seeks to identify and build a sustainable business around the most promising idea.

Siren

Series A in 2018
Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

Vium

Series B in 2018
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

CTRL-Labs

Series B in 2018
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in non-invasive neural interface technology that transforms human-machine interaction. The company has developed CTRL-kit, a wristband equipped with sensors that captures and translates neural signals into control inputs for digital devices. This innovative platform addresses key challenges in virtual and augmented reality, robotics, productivity, and clinical research by allowing developers to integrate neural control into their applications through an SDK and API. CTRL-Labs aims to establish a new paradigm in human-computer collaboration, positioning itself for future consumer adoption of technology that enables seamless interaction between users and machines. Through its scientific initiatives and partnerships, CTRL-Labs is paving the way for advanced applications of its neural interface technology across various industries.

Datavant

Venture Round in 2018
Datavant, Inc. is a health data platform company based in San Francisco, California, founded in 2017. The company specializes in aggregating and analyzing biomedical data using machine learning to enhance the efficiency of drug development. It focuses on improving the clinical trial process by employing artificial intelligence and organizing healthcare data to derive actionable insights for trial design and interpretation. By facilitating secure and accessible data connectivity, Datavant enables over 60 million healthcare records to be exchanged among thousands of organizations, including more than 70,000 hospitals and clinics. The company serves the clinical development and commercial pharmaceutical sectors, as well as researchers, and aims to improve patient outcomes while protecting patient privacy through its innovative platform.

Virta Health

Series B in 2018
Virta Health Corp. is an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company utilizes a combination of nutritional biochemistry, clinical expertise, and data science to develop innovative treatments. Through its continuous remote care platform, Virta provides medical and behavioral support that enables patients to achieve significant health improvements, including lower blood sugar levels and weight loss. Clinical trials have shown that 60% of enrolled patients achieved diabetes reversal within one year, while 94% of insulin users were able to reduce or eliminate their insulin use. Additionally, the benefits of Virta's treatment extend to metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index.

Siren

Seed Round in 2018
Siren Care, Inc. is a San Francisco-based company founded in 2015 that specializes in wearable health technology for diabetic health tracking. The company has developed an innovative product, the Siren diabetic socks, which continuously monitor foot temperature—an early indicator of potential injuries that can lead to ulcers. This smart sock system allows for real-time tracking and sends temperature data to healthcare providers, enabling them to detect early signs of inflammation and other complications in at-risk patients. By engaging with healthcare providers and payers, Siren Care aims to improve the management of chronic diseases, particularly diabetes, and enhance patient outcomes through its comprehensive Siren Diabetic Foot Program.

Unity Biotechnology

Series C in 2018
Unity Biotechnology, Inc. is a biotechnology company dedicated to the research and development of therapeutics aimed at extending human health span by addressing age-related diseases. The company specializes in clearing senescent cells through the creation of senolytic medicines, which specifically target vulnerabilities unique to these cells while sparing healthy ones. Its lead drug candidates include UBX0101, currently in Phase II clinical trials for musculoskeletal conditions like osteoarthritis, and UBX1325, which is in Phase I trials for diabetic macular edema. Additionally, Unity is developing treatments for various conditions related to aging, including pulmonary and neurological disorders, as well as kidney and liver diseases. Founded in 2009 and headquartered in South San Francisco, California, Unity Biotechnology was previously known as Forge, Inc. before changing its name in 2015.

Collective Health

Series D in 2018
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Unity Biotechnology

Series B in 2017
Unity Biotechnology, Inc. is a biotechnology company dedicated to the research and development of therapeutics aimed at extending human health span by addressing age-related diseases. The company specializes in clearing senescent cells through the creation of senolytic medicines, which specifically target vulnerabilities unique to these cells while sparing healthy ones. Its lead drug candidates include UBX0101, currently in Phase II clinical trials for musculoskeletal conditions like osteoarthritis, and UBX1325, which is in Phase I trials for diabetic macular edema. Additionally, Unity is developing treatments for various conditions related to aging, including pulmonary and neurological disorders, as well as kidney and liver diseases. Founded in 2009 and headquartered in South San Francisco, California, Unity Biotechnology was previously known as Forge, Inc. before changing its name in 2015.

Medal

Seed Round in 2016
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in providing administrator services. Established in 2015, the company focuses on the extraction, transportation, translation, and sharing of medical information. Medal’s services facilitate the efficient review, coordination, referral, analysis, billing, and auditing of healthcare data. As of July 2020, Medal operates as a subsidiary of CIOX Health, enhancing its capabilities in the healthcare information management sector.

Q Bio

Seed Round in 2016
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Collective Health

Series C in 2015
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Genesis Healthcare

Venture Round in 2015
Genesis Healthcare Co. is a privately-owned genetic testing and research company founded in 2004 and headquartered in Tokyo, Japan, with additional offices in Singapore and Taiwan. The company is recognized as a market leader in consumer genetics in Japan, offering its services under the brand "GeneLife." Genesis Healthcare possesses the largest genetic database in Japan and Asia, encompassing over 988,000 individuals and more than 1,500 diseases. The company utilizes advanced technologies such as PCR, Microarray, and NGS for research and clinically validated genetic testing services. In addition to its commercial offerings, Genesis Healthcare collaborates with government agencies to establish genetic testing guidelines, ensuring accuracy and the protection of individuals' genetic information. By promoting preventive healthcare through genetic testing, Genesis Healthcare aims to enhance public health outcomes across Southeast Asia.

Vium

Series A in 2015
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Collective Health

Series B in 2015
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Collective Health

Series B in 2015
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Misfit Wearables

Series C in 2014
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Vium

Series A in 2014
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Collective Health

Series A in 2014
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Misfit Wearables

Series B in 2013
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Ringadoc

Venture Round in 2013
Ringadoc operates as a healthcare technology company specializing in virtual communication software for medical professionals. Its platform facilitates secure, cross-platform conversations between doctors, patients, office staff, and other providers, enhancing patient-doctor interaction while streamlining workflows for healthcare practitioners. Led by Founder and CEO Jordan Michaels, Ringadoc aims to improve doctor-patient relationships and simplify healthcare communication processes.

Medtech For Solutions

Venture Round in 2012
Med-Tech Solutions, Inc. is a Canadian company based in Vancouver, specializing in the design, development, and marketing of specialty medical devices focused on women's health care. Founded in 2004, the company holds a license to manufacture, market, and distribute a medical pessary device known as Gynecone, which is utilized in the treatment of female urinary incontinence. In addition to Gynecone, Med-Tech Solutions designs various pessary devices specifically for addressing prolapsed tissue. In 2007, the company underwent a reverse merger, becoming part of The Four Rivers BioEnergy Company Inc.

Misfit Wearables

Series A in 2012
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

100Plus

Seed Round in 2011
100Plus is a rapidly growing remote patient monitoring platform designed to enhance the management of chronic patients, particularly among the elderly. The company provides an integrated solution that includes patient outreach, device setup, patient engagement, and automatic billing, all without requiring smartphones, apps, Bluetooth, or WiFi. This simplifies the process for both patients and healthcare providers. By delivering fully configured medical devices at no cost to Medicare patients or practices, 100Plus facilitates continuous monitoring of high-risk seniors, enabling healthcare professionals to proactively engage with patients. This approach aims to reduce the need for expensive episodic care and improve overall quality of life for patients.

GoodRx Holdings

Seed Round in 2011
GoodRx Holdings, Inc. operates a prescription drug price comparison platform aimed at helping consumers find lower prices on medications across the United States. The platform aggregates pricing data from local and mail-order pharmacies, allowing users to compare costs for both generic and brand-name drugs. In addition to price comparisons, GoodRx offers pharmacy coupons, alerts for manufacturer co-pay cards, and information on state discount programs, all designed to assist consumers in reducing their prescription expenses. The company covers a wide range of health conditions, including allergies, diabetes, mental health issues, and many others. Founded in 2015 and based in Santa Monica, California, GoodRx generates revenue primarily through partnerships with pharmacy benefit managers, facilitating transactions between consumers and pharmacies.

HeartLab

HeartLab is a leading provider of cardiac imaging solutions, specializing in the development of AI-based diagnostic tools aimed at improving the diagnosis and treatment of cardiovascular diseases. The company's platform integrates the entire imaging workflow, enhancing collaboration among healthcare professionals and streamlining processes to improve efficiency and outcomes. By utilizing advanced deep learning technologies, HeartLab's tools enable clinicians to extract detailed information from echocardiograms while automating repetitive tasks, significantly reducing the time required for measurements and interpretations. This focus on enhancing the practitioner experience aims to accelerate advancements in cardiology and elevate care for patients worldwide.

HeartLab

HeartLab is a leading provider of cardiac imaging solutions, specializing in the development of AI-based diagnostic tools aimed at improving the diagnosis and treatment of cardiovascular diseases. The company's platform integrates the entire imaging workflow, enhancing collaboration among healthcare professionals and streamlining processes to improve efficiency and outcomes. By utilizing advanced deep learning technologies, HeartLab's tools enable clinicians to extract detailed information from echocardiograms while automating repetitive tasks, significantly reducing the time required for measurements and interpretations. This focus on enhancing the practitioner experience aims to accelerate advancements in cardiology and elevate care for patients worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.